Alba Botanica Hw Sunscreen Aloe Vera Spf30

Avobenzone, Homosalate, Octocrylene, Octyl Salicylate


The Hain Celestial Group, Inc.
Human Otc Drug
NDC 61995-2008
Alba Botanica Hw Sunscreen Aloe Vera Spf30 also known as Avobenzone, Homosalate, Octocrylene, Octyl Salicylate is a human otc drug labeled by 'The Hain Celestial Group, Inc.'. National Drug Code (NDC) number for Alba Botanica Hw Sunscreen Aloe Vera Spf30 is 61995-2008. This drug is available in dosage form of Lotion. The names of the active, medicinal ingredients in Alba Botanica Hw Sunscreen Aloe Vera Spf30 drug includes Avobenzone - 3 g/100g Homosalate - 7.5 g/100g Octisalate - 5 g/100g Octocrylene - 7.5 g/100g . The currest status of Alba Botanica Hw Sunscreen Aloe Vera Spf30 drug is Active.

Drug Information:

Drug NDC: 61995-2008
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Alba Botanica Hw Sunscreen Aloe Vera Spf30
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Avobenzone, Homosalate, Octocrylene, Octyl Salicylate
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: The Hain Celestial Group, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Lotion
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:AVOBENZONE - 3 g/100g
HOMOSALATE - 7.5 g/100g
OCTISALATE - 5 g/100g
OCTOCRYLENE - 7.5 g/100g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 21 Sep, 2017
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 09 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part352
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:The Hain Celestial Group, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0724742008253
UPC stands for Universal Product Code.
UNII:G63QQF2NOX
V06SV4M95S
4X49Y0596W
5A68WGF6WM
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
61995-2008-4113 g in 1 TUBE (61995-2008-4)21 Sep, 2017N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Sunscreen

Product Elements:

Alba botanica hw sunscreen aloe vera spf30 avobenzone, homosalate, octocrylene, octyl salicylate citrus aurantium fruit oil triethyl citrate sodium stearoyl glutamate glycerin water vinylpyrrolidone/hexadecene copolymer .alpha.-tocopherol acetate glyceryl stearate se potassium sorbate cetyl alcohol dimethicone green tea leaf xanthan gum cetostearyl alcohol polysorbate 60 medium-chain triglycerides cetearyl olivate sodium chloride sorbitan olivate sodium benzoate mango pineapple papaya hibiscus sabdariffa flower passiflora incarnata flower guava citric acid monohydrate homosalate homosalate octisalate octisalate octocrylene octocrylene avobenzone avobenzone alcohol benzyl alcohol aloe vera leaf linalyl acetate

Indications and Usage:

Helps prevents sunburns. if used as directed with other sun protection measures, decreases risk of skin cancer and early skin aging caused by sun exposure. skin protection measures: spending time in the sun increases your risk of skin cancer and early skin aging. to decrease risk, regularly use sunscreen with broad spectrum spf 15 or higher and other protective measures including: limit time in sun, especially from10am to 2pm, and wear long sleeved shirts, pants, hats and sunglases.

Warnings:

For external use only. do not use on damaged or broken skin. when using this product keep out of eyes. rinse with water to remove. stop use and ask a doctor if skin rash occurs.

Dosage and Administration:

Apply liberally 15 minutes before sun exposure. reapply after 80 minutes of swimming or sweating, immediately after towel drying and at least every 2 hours.

Package Label Principal Display Panel:

Al00825 label


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.